Implementation of the NUMSAS Scheme
Published: Thu, 03/23/17
Implementation of the NUMSAS Scheme Conversion from PURMS to NUMSAS A NOTE FROM PHARMAPLUSThis email was recently sent to contractors from LPCs. We…
Important News from the World of Community Pharmacy. Includes reviews, news, events, training and much more!!
Published: Thu, 03/23/17
Implementation of the NUMSAS Scheme Conversion from PURMS to NUMSAS A NOTE FROM PHARMAPLUSThis email was recently sent to contractors from LPCs. We…
Published: Wed, 03/22/17
Business Rates Are you paying the right amount? Read the article below to see if you are paying too much in business rates ... You need to contact…
Published: Tue, 03/21/17
Buttercups Pre-regRecruitment Service Advertise your Pre-reg Placement through Buttercups Training! Click here! A MESSAGE FROM EMMA SETON CHIEF…
Published: Tue, 03/21/17
ANNUAL SOCIAL EVENT8th JULY 2017, Victoria Embankment, LONDONDinner | Drinks | Lu ury Yacht Cruise Pharmaplus is delighted to invite all members to…
Published: Mon, 03/20/17
Upcoming DeadlinesACTIONS NEEDED 31st March 2017: A Number of Deadlines to Meet The end of the financial year (31st March 2017) is fast approaching…
Published: Mon, 03/20/17
Quality Payment'Fi ' Video - Additional Information Video 8 - NHS ChoicesFurther Information FURTHER TO THE EMAIL SENT EARLIER TODAY, PLEASE NOTE THAT…
Published: Mon, 03/20/17
Quality Payment 'Fi ' Video Video 8 - NHS Choices The quality payment video for this week concentrates on how to update your NHS Choices profile. This…
Published: Thu, 03/16/17
Flu Vaccination Deal Complete the form attached to take advantage. Deadline for return: 24th March 2017 As you are undoubtedly aware, the preparations…
Published: Wed, 03/15/17
PharmaPlus Conference Presenter Slides Presenter Slides Now Available for Download Thank you again for all of you who attended the PharmaPlus…
Published: Tue, 03/14/17
CLASS 3 ALERT CLASS 3 ALERT CLASS 3 DRUG ALERT We have received a drug alert from Aspen Medical Europe Ltd on SORBSAN · MHRA drug alert link: N/A ·…